相关实验视频
Updated: Mar 3, 2026

16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
36.1K
人工智能在心力衰竭中的作用
Xueqin Li1, Yu Liu1, Xianya Zhang2
1Department of Medical Ultrasound, Minda Hospital of Hubei Minzu University, Enshi, Hubei, China.
概括
人工智能 (AI) 正在改变心力衰竭 (HF) 的管理,超越"一刀切"的治疗方法. 这篇评论探讨了人工智能.
科学领域:
- 心血管医学和人工智能
- 数字健康和精准医学数字健康和精准医学
背景情况:
- 心力衰竭 (HF) 是一个日益严重的全球健康问题,影响着数百万人.
- 当前的HF管理指南显示治疗疗效的变化,需要个性化方法.
- 人工智能 (AI) 越来越多地被整合到心血管研究中,但对HF的临床翻译仍然有限.
研究的目的:
- 在整个高频临床过程中对人工智能应用进行全面审查.
- 分析AI在高频发展的前景和挑战.
- 为未来临床转型和研究优化高频AI提供见解.
主要方法:
- 对AI在高频患者诊断和亚型化中的应用进行系统审查.
- 在预后评估和治疗反应预测中对AI的评估.
- 对HF患者的治疗前后监测和远程护理中AI的评估.
主要成果:
- 人工智能在各种高频管理阶段展示了潜力,从诊断到远程护理.
- 具体的AI应用包括患者分层,风险预测和个性化治疗策略.
- 该审查强调了人工智能在加强高风患者监测和远程护理方面的作用.
结论:
- 人工智能为个性化HF护理提供了一个有希望的途径,解决了当前方法的局限性.
- 人工智能的临床转化仍然存在挑战,需要进一步的研究和验证.
- 未来的方向侧重于开发强大的AI系统,以无集成到临床实践中.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Heart Failure VI: Adjunct Therapies
477
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
477
Heart Failure V: Medical Management
429
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
429
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Heart Failure IV: Classification and Diagnostic Evaluation
491
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
491
Heart Failure I: Introduction
1.1K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K

